Singulair, Montelukast News

The new Merck & Co. has become the world's second-biggest drugmaker overnight with a huge acquisition, but it still has a fat wallet and plans more wheeling and dealing.

LEXINGTON, Ky. Children who have been prescribed steroidal inhalers to control asthma symptoms should continue to use them, despite questions raised by a medical study concerning their long-term benefits.

Merck & Co., a Dow component and the world's eighth-biggest drug maker by revenue, reports earnings for the third quarter on Thursday morning.

The following is a summary of key developments and analyst opinion related to the period.

A Warren County couple's campaign to warn the public about the potential psychological side effects of a popular asthma and allergy medicine reached a milestone with drug maker Merck & Co.

EMS is called to the house of a 12-year-old male patient in severe respiratory distress.

Insomnia and depression are often symptoms that show up in the same conditions like PTSD, but could also be side effects associated with certain medications .

The American Lung Association's Asthma Clinical Research Centers completed the largest and most comprehensive study to evaluate placebo effects in patients with asthma.

Singulair , Accolate , Zyflo and Zyflo CR have modified their labeling to include information about neuropsychiatric events occurring in patients using these products.

FDA on Friday announced that the labeling for leukotriene inhibitors now includes information about reports of neuropsychiatric events in patients who used the products.

U.S. District Judge Garrett E. Brown Jr. upheld the patent for Singulair, which as Merck's top-selling drug provides about one-sixth of its annual revenue.

The patent for Merck & Co.'s blockbuster allergy and asthma drug is valid, a federal judge ruled Wednesday, handing the drugmaker a crucial victory in its 21/2-year legal battle to block a rival from selling a cheaper generic version.

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials and upcoming FDA approvals & decisions.

The patent for Merck & Co.'s blockbuster allergy and asthma drug is valid, a federal judge ruled Wednesday, handing the drugmaker a crucial victory in its 2 1/2-year legal battle to block a rival from selling a cheaper generic version.

Shareholders of drugmakers Merck & Co. and Schering-Plough Corp. on Friday both overwhelmingly backed a huge tie-up of the New Jersey neighbors, and shares of both companies jumped.

Amazoness Abstract OBJECTIVE: To examine whether outpatient post-stabilization therapy with montelukast produces more treatment failures than prednisolone.

NEW YORK, NY August 07, 2009 a 'More than 99 percent of shareholders of drugmaker Schering-Plough support being bought by bigger New Jersey neighbor Merck.

Shareholders will decide today whether two New Jersey drug companies will become the world's second-biggest drugmaker.

THE FDA HAS REQUESTED that a psychiatric warning be added to the labels of leukotriene inhibitors such as montelukast , zafirlukast , and zileuton , used to treat asthma and, in the case of montelukast, allergic rhinitis.

Dear Dr. Gott: I am a 55-year-old, 5-foot-2, 137-pound female. I work full time at a busy office where I do little sitting.